Nikki Hafezi

Nikki Hafezi is the Managing Director and CEO of GroupAdvance Consulting and EMAGine SA, which provide business development and fundraising advice to companies in the medical technology field, and develop, manufacture and market medical products to address unmet ophthalmic needs. She is also in charge of business strategy and development at the ELZA institute, a new eye hospital and research center in Zurich. Her current focus is translating CXL technology to treat infectious keratitis into clinical applications

Content by Nikki Hafezi:

Business & Profession Professional Development

Earning a Place at the Table

09/30/2021 | Nikki Hafezi

How do you make a name for yourself in ophthalmology, when you’re carrying a name that’s already big in the field?

Subspecialties Cornea / Ocular Surface

When the Rubber Hits the Road

03/04/2021 | Nikki Hafezi

The path to commercializing an ophthalmic product is long and winding – here are some obstacles you might come across along the way

Subspecialties Cornea / Ocular Surface

The Route to K-MAP

09/14/2019 | Emilio de Almeida Torres-Netto, Nikki Hafezi

The ongoing K-MAP study is investigating worldwide keratoconus prevalence among pediatric patients.

Business & Profession Cornea / Ocular Surface

Lighting the Way for Corneal Cross-Linking

12/03/2015 | Nikki Hafezi

The Light for Sight foundation provides ophthalmologists around the world with CXL training and ensures that no young patient must go without treatment

Business & Profession Professional Development

You Have a Great Idea. Now What?

11/13/2014 | Nikki Hafezi

Necessity is the mother of invention: a problem needs solving, someone has a good idea, an invention is born. In clinical medicine, ideas often arise from the act of treating a patient